Video & Transcript Research : 'benzodiazepine analogs'

Page 1 of 92
OK

Oklahoma 2026 Regular Session

Health and Human Services REVISED Apr 13th, 2026

Health and Human Services

Summary: The Senate Health and Human Services Committee first considered three executive nominations. Shonda Lasseter was reappointed to the State Board of Pharmacy, with discussion focused on pharmacy staffing shortages, PBMs, and broader health care workforce challenges; she was advanced 11-0. Dr. Lane Sabara was renominated to the Health Care Workforce Training Commission, where members discussed rural physician shortages and training pipelines; he was advanced 12-0. Dr. Paul Wright was nominated to fill an unexpired term on the same commission and was advanced 12-0 after questions about his availability and experience supporting rural medicine. The committee then heard several health-related bills. HB 3767, which adds 14 chemicals used to enhance fentanyl to Oklahoma’s controlled substances schedules, advanced 10-0. HB 3934, a dentistry workforce and cleanup bill updating insurance-claim and billing language, advanced 11-0. HB 4199, creating a three-year tri-share workforce pilot program for the Department of Commerce, was amended to change eligibility language and then advanced 9-2. HB 2947, allowing supervised behavioral health interns to bill Medicaid, advanced 10-1. HB 3834, authorizing the Department of Health to begin stage-one clinical trials for ibogaine and creating a revolving fund for that purpose, drew extensive testimony about veteran and first responder treatment, safety, funding, and state liability, and advanced 10-2. Additional measures also moved forward. HB 4302, after amendment, advanced 12-0 on a juvenile oversight reporting and law enforcement notification issue. Committee member bills included HB 495, reinstating the 211 Collaborative advisory council, which advanced 11-0; HB 3287, requiring domestic violence and human trafficking signage in health facilities, which advanced 11-0; HB 3649, allowing the Mental Health Department to sell underused property and keep the proceeds in its trust, which advanced 12-0 after amendment; HB 4430, clarifying malpractice coverage for APRNs and PAs at state facilities, which advanced 12-0; HB 2059, creating a mechanism to reimburse medication costs for incarcerated people in county and municipal jails, which advanced 12-0 after questions about continuity of care; and HB 3647, creating an all-payer claims database and transparency board, which advanced 10-2. The committee adjourned after announcing another meeting the following week.
OK

Oklahoma 2026 Regular Session

Criminal Judiciary REVISED: HB3996 - Added Feb 17th, 2026

Criminal Judiciary

Summary: The committee heard and advanced a long agenda of criminal justice bills, with most measures receiving due pass recommendations after brief explanations and little or no debate. Early bills included HB 3586 on modifications to the charging process for abuse and neglect, HB 3584 on sentencing changes for human trafficking involving minors and people with mental disabilities, HB 3587 on outpatient treatment procedures for individuals in the criminal justice center, HB 3743 on community-based outpatient restoration treatment under a PCS and amendment, and HB 3742 on criminal discovery process changes. All of these were reported out favorably, generally by unanimous or near-unanimous votes. Members also advanced HB 4227, Trey’s Law, which would protect child sexual abuse survivors by allowing claims and limiting nondisclosure agreements; HB 3764, which increases penalties for people charged while on the DOJ terrorist list, after an amendment changing the proof language; HB 3767, an Oklahoma Bureau of Narcotics request adding controlled substances and updating terminology; HB 3606, allowing court review for removal from the sex offender registry in cases of medical infirmity or cognitive decline; HB 3299, creating a new offense for unauthorized digitized or synthetic media intended to cause harm; HB 3835, a human trafficking prevention bill; HB 3244, expanding fraud and identity theft laws; and HB 4130, addressing online sweepstakes/casino gaming enforcement with an amendment clarifying tribal gaming under federal law. HB 318 and HB 3302 were laid over. Later, the committee approved HB 3053, creating a narrow parole pathway for incarcerated people age 65 and older, with amendments excluding violent offenses, sex offenses, and certain other crimes; HB 3269, allowing electronic arrest warrants; HB 3301, aligning state law with federal law on short-barreled firearms after an amendment restoring the 16-inch language; HB 3430, revising court fines and fees collection and distinguishing permanent from temporary inability to pay; HB 3497, clarifying when the state may appeal a pretrial order; HB 3755, requiring OJA to provide prescribed medication and medical information to detention facilities within 48 hours for juveniles in custody; HB 3848, easing transitional housing restrictions for released sex offenders; HB 3903, requiring domestic violence incident reports and filing of VPO petitions and adding judicial training; HB 3905, allowing counties to use available funds for GPS monitoring in domestic violence cases; HB 3996, requiring OIDS to pay for expert witnesses in capital post-conviction cases; HB 4142, expanding explosives laws to cover attempts and intent; HB 1322, creating a public registry for persistent domestic violence offenders; and HB 4108, expanding critical infrastructure trespass laws to include airports. Most bills were reported due pass, with votes commonly ranging from unanimous to a few dissenting votes, and the chair recessed/adjourned after the agenda was completed.
OK
Summary: The House opened with roll call, prayer, the Pledge of Allegiance, and several recognitions, including Veteran of the Week Donald W. DeLap, 2025 Oklahoma Teacher of the Year Melissa Yvonne, Doctor of the Day Dr. Corey Shawnaway, Nurse of the Day Rusty Rutherford, and Psychologist of the Day Dr. Glenna Stumbling Bear Riddle. Members also recognized Bob Wills Day at the Capitol with a resolution and musical presentation, and introduced visiting student groups and pages. The chamber then moved into second- and third-reading business on a series of bills. Several measures passed with little or no opposition. House Bill 2975, a Department of Agriculture cleanup bill on poultry litter spreading/exporting, passed 89-8 after questions about removed misdemeanor language and hauler information. House Bill 3026, allowing children of U.S. military allies to start kindergarten according to their home-country timelines, passed 97-0 and its emergency clause also passed 97-0. House Bill 3297, creating a regulatory framework for highway remediation services, passed 87-0. House Bill 2981, requiring school boards to post approved meeting minutes within two weeks and within two clicks, passed 93-0. House Bill 4144, clarifying that arrest and incident reports are open records, passed 97-0. House Bill 1818, updating social work licensing terminology, also passed 97-0. House Bill 3767, updating controlled dangerous substance scheduling to match federal law and DEA watch lists, passed later in the day. The most extended debate centered on House Bill 3194, which would protect pregnancy resource centers from being singled out for regulation or lawsuits. Supporters argued the bill would shield private nonprofit centers from post-Dobbs legal attacks and let them focus on helping pregnant women and families. Opponents raised concerns about transparency, oversight of private nonprofits receiving state funds, the bill’s abortion definition, and whether it could create liability or reduce accountability. After lengthy debate, the House passed the bill 79-18. House Bill 3342, relating to Medicaid audits, passed 67-25 after discussion about making audits corrective rather than punitive. House Bill 3344, a foster care bill based on an interim study, was extensively debated over kinship placement standards, income thresholds, sleeping arrangements, transportation, tribal placement issues, and whether codifying DHS rules would improve accountability; the transcript cuts off before a final vote is shown.
KY
Transcript Highlights:
  • /c><00:20:00.720><c> would</c><00:20:00.880><c> make</c><00:20:01.039><c> an</c><00:20:01.280><c> analogy
  • /c><00:20:01.760><c> I</c><00:20:01.919><c> would</c><00:20:02.080><c> say</c> If I would make an analogy
  • , I would say If I would make an analogy, I would say that<00:20:02.480><c> you've</c><00:20:02.799><
  • Physiological dependence is a property of many medicines, including benzodiazepines and antidepressants
  • Yes, it's costly, and we've seen outside in the community here the co-prescribing of benzodiazepines,
Keywords: 958, all
Summary: The subcommittee met on October 14, approved the minutes, and then took up a large group of staff-suggested amendments to multiple regulations. Those staff amendments were approved without objection and were described as technical changes needed to comply with KRS Chapter 13A and other governing law. The committee then moved out of order to consider Kentucky Board of Medical Licensure regulation 2011 KAR 9:270, which governs buprenorphine prescribing and related standards. Board representatives said the regulation has been updated over time since 2015 and that the current amendments are intended to streamline the rule, remove outdated federal references such as the X-waiver, narrow education requirements to addiction-related topics, and create exceptions for settings like emergency rooms and certain pain treatment situations. The agency amendment would also allow buprenorphine monoproduct for up to 30 days when a patient is transitioning from a full opioid agonist, and would add physicians certified in addiction medicine as eligible specialty consultants. Board officials said the regulation was developed through a two-year process with a work group, informal outreach to medical organizations, and multiple comment periods, and they argued the rule is working because overdose deaths have declined and provider numbers have increased. Several witnesses and committee members raised concerns that the regulation remains too restrictive. Senator Rocky Adams noted that major medical organizations had said the proposed language could restrict access and worsen overdose risk, and he questioned whether the committee was being asked to choose between conflicting expert views. Opponents, including a medical student, a recovery advocate, and Dr. Colleen Ryan of the Kentucky Society of Addiction Medicine, argued the rule is outdated, creates unnecessary barriers to buprenorphine treatment, and should be repealed or substantially revised to align with federal guidance and evidence-based care. They said rigid requirements can discourage treatment and that addiction should be treated like other chronic illnesses. No final vote on the medical licensure regulation is reflected in the transcript excerpt, and the discussion ended with the chair preparing to hear from additional opponents.
OK

Oklahoma 2026 Regular Session

Senate Legislative Session Apr 13th, 2026

Oklahoma Senate Floor Meeting

Summary: The Senate convened, established a quorum, offered the invocation and pledges, and recognized the doctor, psychologist, and nurse of the day. The chamber then hosted several honorary introductions and citations, including congratulations to the Murray State College shotgun team for winning back-to-back national championships and to the Coedah High School varsity wrestling team for a record-setting 5A season and state title. Both groups were formally presented citations and received Senate applause. The Senate also considered Senate Resolution 30, which reaffirmed Oklahoma’s sister-state relationship with Taiwan, supported stronger economic and diplomatic ties, and celebrated the anniversaries of the Taiwan Relations Act and the Oklahoma-Taiwan relationship. The resolution was adopted by voice vote after brief remarks from Senator Peterson and a representative from Taiwan’s office in Houston, who thanked the Senate and spoke about Taiwan’s trade relationship, economic growth, and international challenges. The meeting included introductions from several student pages, who described their schools, sponsoring senators, and future plans. Announcements were made for committee meetings, including Revenue and Taxation, Health and Human Services, and Appropriations and Budget, along with a reminder about Diabetes Awareness Day. The Senate then adjourned until Tuesday, April 14th at 9:30 a.m.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Mental Health, Substance Use and Recovery Jun 21st, 2026 at 01:00 pm

Joint Committee on Mental Health, Substance Use and Recovery

Transcript Highlights:
  • I never needed a benzodiazepine.
  • exposure and the non-benzodiazepine drugs.
  • non-benzodiazepine hypnotics.
  • Thank you for holding this hearing today for House Bill H. 2,223, and act relative to benzodiazepines
  • The list of benzodiazepine symptoms is endless, and yes, benzos are great for short-term treatment of
Keywords: 995, all
Summary: The hearing opened with remarks from House Chair Mindy Domb and Senate Vice Chair Robyn Kennedy, who outlined procedures for the hybrid public hearing, noted the committee would hear testimony on 15 bills related to treatment settings, and recognized members present. The first major bill discussed was H. 4200, authorizing a pilot program for psychedelic-assisted treatment in licensed facilities. Representative Jim O’Day and witnesses from Control Z supported the bill, describing it as a tightly controlled, medically supervised pilot with DPH oversight, limited sites, and screening requirements. Committee members asked about the number of sites and whether Column Health still existed; witnesses said the bill contemplated three separate pilot programs and that Column Health no longer existed after being purchased by another company. The committee also heard testimony on S. 1405 to make the drug stewardship program permanent by removing its 2026 sunset date. Senator John Keenan and others said the program helps collect and safely dispose of unused medications, reduces diversion, and should remain in place because manufacturers should bear disposal costs. A member from Boston added support based on local concerns about people searching through bags for drugs, and Keenan explained the original sunset reflected pilot status and industry pushback. A large portion of the hearing focused on S. 1394 and H. 2193, which would strengthen implementation of the 2023 Roadmap for Behavioral Health Reform. The Children’s Mental Health Campaign, Parent/Professional Advocacy League, Massachusetts Association for Mental Health, and Elliott Community Human Services testified that the roadmap’s helpline, community behavioral health centers, and crisis services are important but unevenly implemented. They urged a single point of accountability within EOHHS, regular strategic planning, a public data dashboard, and financial analysis of the behavioral health system and the access and crisis intervention trust fund. Witnesses said commercial insurance often does not fully reimburse community behavioral health center services, making sustainability difficult, and asked for better coordination across agencies and crisis response systems. Committee members asked whether the roadmap includes substance use disorder; witnesses said it is intended to cover behavioral health broadly, including mental health and substance use. The committee also heard testimony on bills to ban aversives and on suicide prevention signage. Lisa Jean Graff testified in support of S. 1394 by urging a statewide ban on aversive practices, including electric shock, withholding food or bathroom access, and other painful interventions, arguing disabled people deserve the same protections from harm as others. Fonda Bryant and Carol McLean supported a bill requiring suicide prevention signs on tall parking garages, describing personal experiences and saying the signs could create a brief pause and connect people to 988 or other help. McLean said her son died by suicide from a parking garage and that signage might have made a difference. The committee also heard strong testimony in support of creating intensive stabilization and treatment units within DMH facilities (S. 1398/H. 2204), with the Massachusetts Nurses Association and a DMH nurse arguing that highly assaultive patients need specialized, more secure units to protect staff and other patients and to improve care. Additional testimony supported creating a dedicated board for licensed mental health counselors (H. 4696/S. 1382), with Rep. John Badger, the Mass Mental Health Counselors Association, and others saying LMHCs are a large and growing workforce that needs its own licensing board, clearer standards, and faster implementation of existing licensure reforms. The committee also heard extensive testimony on H. 2223 regarding benzodiazepines and non-benzodiazepine hypnotics. Survivors and advocates described severe withdrawal, lack of informed consent, cognitive harms, and long-term disability, while a physician supported the bill as a way to improve disclosure of risks. Finally, the committee heard multiple witnesses in favor of H. 2231/S. 1383 to establish peer-run respite centers statewide. Advocates and people with lived experience said peer respites provide non-coercive, home-like alternatives to hospitalization, can reduce trauma and repeated admissions, and may be especially important for marginalized communities; they also cited cost savings and existing positive outcomes from current respite programs. No votes or final committee actions were taken during the hearing portion reflected in the transcript.
OK

Oklahoma 2026 Regular Session

Public Health Feb 11th, 2026

Public Health

Summary: The committee first announced several bills would be laid over because sponsors were absent, then took up House Bill 4423, which would require Medicaid applicants to be legal U.S. citizens. After adopting a PCS, members asked whether Medicaid already had citizenship limits, and the bill passed 4-1. House Bill 3342 followed, revising the Health Care Authority audit process; the sponsor said it was based on an Arkansas model, had no fiscal impact, and was intended to be fairer after prior problems. It passed 5-0. House Bill 3645, allowing physicians or other independent doctors to authorize hospice referral when a patient lacks next of kin or is not coherent, also passed 5-0. House Bill 3647, creating an all-payer claims database through the state HIE for greater transparency in medical costs, passed 5-0 after a question about which entities would be included or excluded. House Bill 3887, which removes the requirement for a physician referral every 30 days for continued physical therapy, drew the most discussion. The sponsor said therapists would refer patients back to a physician if treatment was not helping or was outside their scope, while a member raised concerns about delayed diagnosis and suggested adding a timeline; the sponsor said he would be open to further discussion. The bill passed 4-1. House Bill 4430 extended tort claims protection to certain state-employed providers who work for entities such as FQHCs, and House Bill 4431 did the same for nurse practitioners working for state agencies; both passed 5-0. Later, House Bill 2964 changed medical-record copying language from “shall be charged” to “may be charged,” giving facilities discretion on whether to charge patients for copies of their records; it passed 5-0. Finally, House Bill 3834 was heard for research funding on ibogaine therapy for PTSD and related conditions among veterans, firefighters, and police officers. The sponsor said the goal was to allow Oklahoma research, not to remove the substance from controlled status, and a witness described the treatment as a monitored oral session used in Mexico and supported by some studies. The bill passed 5-0, and the chair adjourned the meeting, noting the laid-over bills would likely be heard the following week.
MO

Missouri 2026 Regular Session

Substance Abuse Prevention and Treatment Task Force Jun 25th, 2026 at 09:00 am

Substance Abuse Prevention and Treatment Task Force

Transcript Highlights:
  • mitragynine pseudoindoxyl and dihydro-7-hydroxymitragynine, or MGM-15, which is a fully synthetic analog
  • highlight, just as we understand Missouri's statutory scheme, is that we do have what's called an analog
  • get into, however, from an enforcement perspective, is as soon as you argue that something is an analog
  • Local law enforcement might not know that a new substance is an analog or homologue.
  • Local law enforcement might not know that a new substance is an analog or homelong.
Keywords: 959, house, all
MO
Transcript Highlights:
  • mitragynine pseudoindoxyl and dihydro-7-hydroxymitragynine, or MGM-15, which is a fully synthetic analog
  • highlight, just as we understand Missouri's statutory scheme, is that we do have what's called an analog
  • get into, however, from an enforcement perspective, is as soon as you argue that something is an analog
  • Local law enforcement might not know that a new substance is an analog or homologue.
  • me to repeat it, I would do it, because we'd be called many times at night to say, what is the benzodiazepine
Summary: The meeting focused on Missouri’s substance use prevention and treatment system, with repeated emphasis on recovery support services, peer support, recovery housing, transportation, and harm reduction. Dan Haniken of Into Action described his own recovery from addiction and incarceration and argued that treatment alone is not enough; he urged greater investment in recovery housing, peer support, employment, and community-based supports that help people stay sober and avoid relapse. Members asked about funding sources, program capacity, referrals, treatment court, transportation, and how Into Action supports people on medication-assisted treatment (MAT). Haniken said the organization is funded through a mix of federal, state, county, city, foundation, and private donations, and that housing and transportation remain major barriers, especially because support is often funded for too short a period compared with the longer time people need to stabilize. Matt Cushman of the Raytown Fire Protection District gave a strong endorsement of harm reduction, including naloxone distribution, syringe service programs, and broader decriminalization of harm reduction tools. He argued that stigma is a major barrier to care and that Missouri should expand access to clean needles, test strips, and other services, while also improving access to MAT in jails and communities. Committee members questioned the evidence base, the role of faith-based providers, and whether safe consumption sites should be pursued; Cushman said syringe exchange decriminalization should be the immediate priority, while safe consumption sites are a longer-term issue. He also described community paramedicine and mobile integrated health as valuable but funding-dependent, and said naloxone distribution is improving but still uneven, especially in rural and minority communities. Representatives from Central Ozarks Medical Center and Four Rivers Community Health Center highlighted the importance of peer support specialists, community health workers, care coordinators, and wraparound services in rural health centers. COMC’s Morgan McClure and Monet Lehman described a jail reentry program in Pulaski County, with Lehman sharing her trauma and recovery story and explaining how she helps incarcerated people prepare for release with housing, employment, benefits, transportation, and treatment connections. Four Rivers’ Devon Polarys and Cassandra Trout said their CEO would change Missouri policy to allow FQHCs to receive reimbursement for peer support and community health worker services similar to CCBHCs, arguing that these roles are essential for addressing barriers like transportation, housing, food insecurity, and insurance. Members discussed confusion over reimbursement rules, the differences between FQHCs and CCBHCs, and the need for better funding and clearer policy for peer and community health worker services. No votes were taken; the discussion ended with a suggestion to bring in a subject matter expert on community health workers for a future session.
UT

Utah 2025 Regular Session

Health and Human Services Interim Committee - November 19, 2025

Health and Human Services Interim Committee

Transcript Highlights:
  • while I was working up at the Center for Human Toxicology as a research toxicologist studying benzodiazepines
  • Studying benzodiazepines and opiates and their drug-drug interactions.
  • Now, just think of this analogy.
Keywords: 985, all
NH

New Hampshire 2025 Regular Session

House Criminal Justice and Public Safety (01/23/2025)

Criminal Justice and Public Safety

Transcript Highlights:
  • that I kind of see you know an analogy that I kind of make<01:05:02.880><c> in</c><01:05:03.039><c>
  • Is there the same kind of analogy like that? I am an expert on the subject.
  • </c> Zine uh which is a new fentanyl analog Zine uh which is a new fentanyl analog uh<04:46:35.798><c
  • And the one that worries me the most is various kinds of benzodiazepines.
  • And the one that worries me the most is various kinds of benzodiazepines.
Keywords: 1189, house, all
MO

Missouri 2026 Regular Session

Substance Abuse Prevention and Treatment Task Force Jun 24th, 2026 at 01:00 pm

Substance Abuse Prevention and Treatment Task Force

Transcript Highlights:
  • curriculum, is that the two drug classes that have deadly withdrawals and detoxes are alcohol and benzodiazepines
  • curriculum, is that the two drug classes that have deadly withdrawals and detoxes are alcohol and benzodiazepines
  • First, an analogy: SUD is just as lethal as colorectal cancer.
  • It's a perfect analogy for substance use disorder.
Keywords: 959, house, all
CA

California 2025-2026 Regular Session

Senate Health Committee Feb 18th, 2026

Health

Transcript Highlights:
  • substantially elevated when 7-OH is taken alongside other intoxicants, particularly alcohol, benzodiazepines
  • Let me give you an analogy. These are not the same products.
  • Let me give you an analogy. Apple seeds contain trace amounts of amygdalin.
  • A simple analogy nicely illustrates why synthetic 7-OH is not kratom.
  • A simple analogy nicely illustrates why synthetic 7-OH is not kratom.
Keywords: 987, senate, all
CA

California 2025-2026 Regular Session

Senate Health Committee Feb 18th, 2026

Transcript Highlights:
  • substantially elevated when 7-OH is taken alongside other intoxicants, particularly alcohol, benzodiazepines
  • Let me give you an analogy. Apple seeds contain trace amounts of amygdalin.
  • A simple analogy nicely illustrates why synthetic 7-OH is not kratom.
  • A simple analogy nicely illustrates why synthetic 7-OH is not kratom.
Summary: The committee held an informational hearing on kratom and 7-hydroxymitragynine (7-OH), focusing on public health risks, overdose deaths, and regulatory gaps in California. The chair opened by noting that FDA and CDPH consider kratom and 7-OH products unlawful, yet they remain widely sold in smoke shops, vape stores, gas stations, and convenience stores. Members referenced AB 1088, which would be considered later, and said the hearing was intended to clarify the science, medical perspective, and whether stronger safeguards are needed. The first panel featured a toxicology expert, state and local public health officials, an emergency/addiction physician, a medical examiner, and county health representatives. Witnesses from CDPH and Los Angeles County described rising deaths and enforcement actions, including statewide advisories, retailer letters, and product removals from manufacturers, wholesalers, and retailers. Medical testimony emphasized that 7-OH acts much more like an opioid than traditional kratom leaf, can cause dependence, withdrawal, and respiratory depression, and may require naloxone, buprenorphine, or methadone in overdose or withdrawal cases. Local officials said enforcement is difficult because packaging is inconsistent, testing capacity is limited, and counties lack resources and statewide infrastructure; they generally favored a centralized state framework if regulation is pursued. Committee members asked about testing, age restrictions, scheduling, and whether a distinction between kratom and 7-OH could be enforced. Witnesses said forensic labs can potentially test for 7-OH but validated assays are not routine, emergency departments cannot readily distinguish exposures, and local health departments do not have the lab capacity to verify product labels. Several officials warned that a ban or abrupt scheduling could push products into the black market and discourage research, while others argued that current prohibition and enforcement are the most protective approach because legalization or age-limited regulation could create confusion about legality and safety. The second panel included kratom and 7-OH advocates and industry representatives, who argued that natural kratom leaf and concentrated or synthetic 7-OH are different products and should be regulated differently. They supported age-gating, labeling, testing, and packaging rules for kratom leaf while opposing a ban on the botanical. They said 7-OH is used by many adults for pain relief or harm reduction, and that prohibition would drive consumers to illicit markets and worsen harm. Committee members pressed them on whether 7-OH is more potent than kratom, the availability of testing, and whether any safe dose is known. The hearing ended without a vote or formal action, with the chair noting the issue will continue to be considered in future legislation.